SNMMI Names Helen Nadel, MD, FRCPC, as President-Elect at 2022 Annual Meeting

June 15, 2022 —Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine atLucile Packard Children’s Hospital at Stanfordand clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, has been named president-elect for theSociety of Nuclear Medicine and Molecular Imaging(SNMMI). SNMMI introduced a new slate of officers during its 2022 Annual Meeting, held June 11-14.

“As SNMMI president-elect, I plan to focus on the future of the field,” said Nadel. “How can we be prepared for future health crises? What can we do to fast-track the development and approval of diagnostic andtheranosticmolecular imaging agents? How can we ensure diversity in all parts of the nuclear medicine family?”

Working with SNMMI members, task forces and committees, Nadel will bring these issues to the forefront of the society’s agenda and will develop programs to address them. Projects will include creating rapid global communication and mobilization plans, fostering the society’s government and industry relationships, and implementing diversity initiatives.

Nadel earned her medical degree from the University of Manitoba in Winnipeg, Manitoba, Canada, in 1977. She completed a diagnostic radiology residency in 1982 at the University of Toronto, followed by a fellowship in pediatric radiology at the Hospital for Sick Children at the University of Toronto, both in Toronto, Ontario, Canada. She then completed a nuclear medicine residency in 1989 at the University of British Columbia, in Vancouver, British Columbia, Canada. Nadel held multiple academic appointments at the University of British Columbia between 1983 and 2018 and was head of the division of nuclear medicine and department of radiology at British Columbia Children’s Hospital before taking on her current roles at Stanford.

Nadel has been an active SNMMI member for more than 30 years, serving as vice president-elect and in the House of Delegates. She also held positions as president of the Pediatric Imaging Council and member of its board of directors, and she has served on the PET Center of Excellence Board of Directors, Scientific Program Committee, Membership Committee and The Journal of Nuclear Medicine Editorial Board, among other posts. She was president of the SNMMI Pacific Northwest Chapter for many years and currently plays an active role in the Northern California chapter.

In the greater nuclear medicine community, Nadel has served in multiple positions for the American College of Nuclear Medicine, the American Board of Nuclear Medicine, theRadiological Society of North America, and the Children’s Oncology Group. In 2019, Nadel received the Lifetime Achievement Award from the European Society of Pediatric Nuclear Medicine for ongoing contributions to pediatric nuclear medicine. She has published 76 peer-reviewed journal articles and 24 book chapters and has been an invited speaker for 180 presentations.

Other SNMMI officers elected for 2022-23 are Munir Ghesani, MD, FACNM, FACR, New York, New York, as president and Cathy Sue Cutler, PhD, FSNMMI, Upton, New York, as vice president-elect. SNMMI Technologist Section officers for 2022-23 are Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, Birmingham, Alabama, as president and Dmitry Beyder, CNMT, MPA, St. Louis, Missouri, as president-elect.

For more information:www.snmmi.org

Find more SNMMI22 coverage here

Related Content

Feature|Magnetic Resonance Imaging (MRI)| Christine Book

August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic ...

TimeAugust 10, 2022
arrow
House-passed Appropriations Bills Include Key Measures to Improve Nuclear Medicine Patient Safety
News|Nuclear Imaging

July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...

TimeJuly 27, 2022
arrow
the findings could be used to inform the committee on BI-RADS regarding the possible incorporation of the MBI lexicon into the BI-RADS Atlas
News|2022世界杯篮球预选赛赛程

July 21, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), understanding the likelihood of malignancy ...

TimeJuly 22, 2022
arrow
NorthStar will provide Clovis with its environmentally preferred, high purity non-carrier-added (n.c.a.) Ac-225
News|Radiopharmaceuticals and Tracers

July 20, 2022 — -NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeJuly 20, 2022
arrow
Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ-targeted positron emission tomography (PET) system, in the United States
News|PET Imaging

July 19, 2022 — Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ ...

TimeJuly 19, 2022
arrow
Iodixanol Injection, USP is the first U.S. FDA-approved generic iso-osmolar, dimeric iodinated contrast media agent, which is used during diagnostic x-ray-based imaging such as computed tomography (CT) scans
News|Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

TimeJuly 18, 2022
arrow
The global molecular imaging market is estimated to be USD 6,750.1 million in 2021 and is expected to witness a CAGR of 7.84% during the forecast period
News|Molecular Imaging

July 11, 2022 — The "Molecular Imaging Market, by Application (Cancer, Heart Disease, Brain Disorder), by Technology ...

TimeJuly 12, 2022
arrow
News|PET-CT

July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

TimeJuly 11, 2022
arrow
Contrast media is used to improve diagnostic imaging, and the shortage has affected millions of examinations.
News|Contrast Media

2022年7月5日—2022年4月,由于中国的“零COVID”政策,上海关闭,导致全球……

TimeJuly 05, 2022
arrow
The ConformalFLASH Alliance will be the first collaboration platform between academia and industry to bring ConformalFLASH proton therapy to the clinic
News|Proton Therapy

July 1, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology ...

TimeJuly 01, 2022
arrow
Subscribe Now